"Electromagnetical Stimulation of Phrenic Nerve to Generate Contraction of the Diaphragm"

NCT ID: NCT04884698

Last Updated: 2022-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-25

Study Completion Date

2021-12-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The scientific study is intended to show that external non-invasive electromagnetic stimulation can be used to safely and effectively stimulate the phrenic nerve in awake healthy subjects as well as in ventilated, anesthetized patients and that the stimulation can generate a diaphragmatic contraction that generates significant breath volume - a Controlled Own Breath (COB).

Also of interest is the reproducibility of the generated diaphragmatic movements and the reliability of different feedback signals for detecting the generated diaphragmatic contraction. This applies to inspiration and expiration detection for subsequent synchronization mechanisms of the magnetic stimulator for patient-initiated breathing as well as to contraction intensity. Further, the characterization of the position finding process is of great importance, so that technical developments can further simplify the process of coil positioning in the future. The possible occurrence of discomfort and pain sensation will also be investigated in awake healthy volunteers. Different stimulation protocols will be used.

Finally, it will be investigated whether an adjusted coil position still triggers reproducible diaphragmatic contractions after removal and repositioning in the same configuration. The knowledge gained will be used to further develop the technique and to prepare a study in critically ill, ventilated patients where the diaphragmatic muscle is to be treated preventively by stimulating the phrenic nerve, in order to prevent atrophy of the muscle.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Subjects Elective Surgical Procedure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Open-label, sponsor-initiated feasibility study. 2 groups of patients treated - healthy subjects and elective surgery patient
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Phrenic nerve stimulation with Stimit Activator

Group Type EXPERIMENTAL

Stimit Activator

Intervention Type DEVICE

The Stimit Activator Device is composed of three components.

1. A magnetic stimulator generating current pulses
2. A novel Stimit coil design optimized for phrenic nerve stimulation
3. A coil positioning device for quick, easy and reproducible coil positioning

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stimit Activator

The Stimit Activator Device is composed of three components.

1. A magnetic stimulator generating current pulses
2. A novel Stimit coil design optimized for phrenic nerve stimulation
3. A coil positioning device for quick, easy and reproducible coil positioning

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persons aged \> 18 years
* Applicable for Group 2: planned for elective surgery
* No relevant pre-existing conditions - corresponding to American Society of Anesthesiologists (ASA) level of I-II.
* Written informed consent by the patient for participation in the study given

Exclusion Criteria

* chronic lung diseases (bronchial asthma, COPD)
* known diaphragmatic weakness
* known neurological conditions with motor muscle weakness
* known paralysis of the phrenic nerve
* conditions that limit the mobility of the diaphragm (high intra-abdominal pressure, ascites, BMI \>30)
* not able to read and understand the national language German
* skin lesions, infections or strictures in the neck area
* persons with Implanted cardiac support systems (pacemaker, implanted defibrillator)
* persons with implanted medical pumps
* pregnant women
* persons deprived of liberty by administrative or judicial decision or under legal guardianship.
* Participation in another clinical trial

* Unstable patient after induction of anesthesia and intubation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stimit AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Baumberger, MD

Role: PRINCIPAL_INVESTIGATOR

Swiss Paraplegic Center Nottwil

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Swiss Paraplegic centre

Nottwil, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Stimit swiss I

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.